Aligned Genetics, Inc.

KOSDAQ:A238120 Stock Report

Market Cap: ₩40.8b

Aligned Genetics Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Yeon-Cheol Jung

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership20.5%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Aligned Genetics, Inc.'s (KOSDAQ:238120) Business Is Yet to Catch Up With Its Share Price

Aug 12
Aligned Genetics, Inc.'s (KOSDAQ:238120) Business Is Yet to Catch Up With Its Share Price

If You Like EPS Growth Then Check Out Aligned Genetics (KOSDAQ:238120) Before It's Too Late

Apr 06
If You Like EPS Growth Then Check Out Aligned Genetics (KOSDAQ:238120) Before It's Too Late

Update: Aligned Genetics (KOSDAQ:238120) Stock Gained 29% In The Last Three Years

Feb 11
Update: Aligned Genetics (KOSDAQ:238120) Stock Gained 29% In The Last Three Years

CEO

Yeon-Cheol Jung (54 yo)

no data

Tenure

Mr. Yeon-Cheol Jung serves as the Chief Executive Officer at Aligned Genetics, Inc. (formerly known as Logos Biosystems, Inc.). Mr. Jung is an Insider at Aligned Genetics, Inc. (formerly known as Logos Bio...